Presentation AHA 2024 Effects of Sacubitril-Valsartan on Prevention of Cardiotoxicity in High-Risk Patients Undergoing Anthracycline Chemotherapy: The SARAH Trial Presenter: Marcely Gimenes Bonatto November 18, 2024
News Conference News AHA 2024 ARNI Lessens Anthracycline Cardiotoxicity in High-Risk Patients: SARAH Caitlin E. Cox November 18, 2024
News Conference News AHA 2024 One Hundred Years and Beyond: What's Going to Be Hot at AHA 2024 Shelley Wood November 14, 2024
News Daily News HFSA Stats 2024 a ‘Call to Action’ Against Rising Tide of HF L.A. McKeown October 01, 2024
News Daily News CVD Risk Twofold Higher in Patients With Cancer: ASPREE Michael O'Riordan September 27, 2024
Presentation ACC 2024 PROACT: Can we prevent chemotherapy-related heart damage in patients with breast cancer and lymphoma? Presenter: David Austin April 08, 2024